Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Clinical Outcomes Of Primary Sclerosing Cholangitis In North America
Sclerosing cholangitis
All genders
No minimum age
Recruiting now
Department of Medicine, Division of Gastroenterology + Hepatology
Exploring the Role of the Mineralocorticoid Receptor in Human Vascular Disease
Vascular diseases
All genders
18+
Recruiting now
Department of Surgery, Division of Vascular Surgery
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology